BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2025 2:50:53 AM | Browse: 65 | Download: 193
 |
Received |
|
2025-10-15 02:17 |
|
Peer-Review Started |
|
2025-10-15 02:17 |
|
First Decision by Editorial Office Director |
|
2025-10-21 09:36 |
|
Return for Revision |
|
2025-10-21 09:36 |
|
Revised |
|
2025-10-28 13:01 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-12 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-12 11:03 |
|
Articles in Press |
|
2025-11-12 11:03 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-16 01:36 |
|
Publish the Manuscript Online |
|
2025-12-27 02:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist’s roadmap for the clinician
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cheng-Long Wang, Min Zeng and Yan Luo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chongqing Health Commission and Science and Technology Bureau |
No. 2023MSXM060 |
|
| Corresponding Author |
Yan Luo, MD, Department of Stomatology, The People’s Hospital of Dadukou District, No. 102 Cuibai Road, Dadukou District, Chongqing 400084, China. luokate88@gmail.com |
| Key Words |
Pathology; Autoimmune gastritis; Gastric neuroendocrine tumors; Precursor lesions; Dysplasia |
| Core Tip |
Clinical risk models identify patients with autoimmune gastritis who may develop neuroendocrine tumors, but pathology guides what to do next. We advocate for a “prognostic biopsy protocol” where pathologists report the specific stage of microscopic pre-cancerous lesions. Finding high-risk changes, especially dysplasia, serves as a clear trigger to intensify surveillance. This approach allows clinicians to manage risk proactively based on a patient’s real-time biology, rather than waiting for a visible tumor to develop. |
| Publish Date |
2025-12-27 02:50 |
| Citation |
Wang CL, Zeng M, Luo Y. Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist’s roadmap for the clinician. World J Gastroenterol 2025; 31(48): 115244 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i48/115244.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i48.115244 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
